Free delivery on all NHS prescriptions — order now
Salamol
Images for illustrative purposes only
Salamol is a fast-acting reliever inhaler containing the active ingredient salbutamol, specifically designed to provide rapid relief from bronchospasm associated with asthma and COPD.
- Rapid onset within 5 minutes
- CFC-free eco-friendly propellant
- Available in Easi-Breathe format
- NHS & Private prescription fulfilment
More information
Salamol is a standard-of-care rescue medication typically prescribed to manage acute symptoms of reversible airways obstruction in conditions like asthma, chronic obstructive pulmonary disease (COPD) and exercise-induced bronchospasm. It acts as a short-acting beta-2 agonist (SABA) to quickly relax lung muscles and open the airways during a flare-up or before exposure to known triggers like pollen or cold air. — Rachael Clarke MRCPharm MFRPSI FRSPH (GPHC Number: 2061366)
You can purchase Salamol via Mail my Meds following a convenient online consultation with a registered prescriber to ensure the medication is clinically appropriate for your respiratory health. Once your consultation is approved, your medication is dispensed and shipped directly from our pharmacy (GPHC Number: 9011560) using discreet, secure home delivery.
Prices for Salamol may vary based on whether you are fulfilling a repeat NHS prescription or a private order. Mail my Meds provides transparent pricing for all asthma treatments, ensuring competitive rates compared to high-street pharmacies.
Mail my Meds offers multiple delivery options including tracked next-day delivery and standard Royal Mail services to ensure your rescue medication arrives promptly. All inhalers are packaged in discreet, tamper-evident materials to maintain patient confidentiality and product integrity during transit.
Salamol is a bronchodilator medication used to provide immediate relief from symptoms of asthma, such as wheezing, chest tightness and shortness of breath. While it is primarily used during an "attack," it is also frequently used 10 to 15 minutes before exercise or exposure to allergens to prevent the onset of breathing difficulties.
The active ingredient in every puff of Salamol is salbutamol sulfate, which is delivered at a strength of 100 micrograms per metered dose. Unlike older inhalers, Salamol utilises a CFC-free propellant known as HFA-134a, which is significantly more environmentally friendly while delivering the same therapeutic efficacy.
Users frequently report that Salamol is highly effective at stopping an asthma attack quickly, with most feeling an improvement in their breathing within 5 minutes. Some patients transitioning from Ventolin note a slight difference in the "taste" or "force" of the spray due to the different HFA propellant levels, but clinical outcomes remain identical.
A physical Patient Information Leaflet (PIL) is included in every medication box, providing comprehensive details on usage and safety. You can also access digital versions of the Salamol PIL via the electronic Medicines Compendium (emc) to review full clinical data before starting treatment.
Salamol works by stimulating beta-2 receptors in the lungs, which causes the smooth muscles surrounding the bronchioles to relax and widen. This process, known as bronchodilation, allows air to flow more freely into the lungs, reversing the constriction caused by inflammatory triggers or physical exertion.
To use a Salamol CFC-Free inhaler, you must shake the canister well, exhale fully, and then coordinate a slow, deep breath with a single press of the canister. For those using the Salamol Easi-Breathe version, the device is breath-actuated, meaning it automatically releases the dose as you inhale, removing the need for coordination.
| Requirement | Standard Dose (Adults & Children) |
|---|---|
| Relief of acute symptoms | 1 to 2 puffs (100–200mcg) as needed |
| Preventing exercise-induced asthma | 2 puffs (200mcg) taken 10–15 mins before |
| Maximum daily limit | 8 puffs (800mcg) in any 24-hour period |
Common side effects of salbutamol include a mild tremor (shaking), headaches, or a faster heartbeat (palpitations), which usually resolve as the medication wears off. Although rare, serious side effects can include muscle cramps or an irregular heartbeat; if you experience these, you should contact a healthcare professional immediately.
Before using Salamol, inform your prescriber if you have heart disease, an overactive thyroid, or diabetes, as salbutamol can occasionally affect blood sugar and potassium levels. According to NICE guidelines, if you find yourself needing your reliever inhaler three or more times a week, it indicates your asthma may be poorly controlled, and you should have a clinical review.
Salamol and Ventolin both contain 100mcg of salbutamol and are clinically bioequivalent, meaning they work in the exact same way to relieve asthma symptoms. The primary difference is that Salamol has a much lower carbon footprint (approx. 11.95kg CO2e) compared to Ventolin (approx. 28.26kg CO2e), leading the NHS to favour Salamol as a more sustainable choice for UK patients.
Is Salamol the same as Ventolin?
Yes, Salamol is a brand of salbutamol inhaler that contains the same active ingredient as Ventolin and provides the same medical relief for asthma and COPD.
Can I use a spacer with Salamol?
Yes, using a spacer device like an AeroChamber with your Salamol pMDI can help ensure more of the medicine reaches your lungs rather than the back of your throat.
Why does my new Salamol inhaler taste different?
Salamol uses a different HFA propellant and a slightly different formulation than other brands, which may result in a different taste or sensation, but this does not affect how well it works.
This information is provided for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your GP, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition.
Our medical content is regularly reviewed by a team of healthcare experts to ensure all information aligns with current BNF and NICE clinical guidelines.

